The study investigated the reversal of multidrug resistance (MDR) and the biodistribution of nanoparticles (NPs) that target
leukemia cells in a nude mice model via a surface-bound
transferrin (Tf). The cytotoxic cargo of
daunorubicin (DNR) and
tetrandrine (Tet) was protected in the NPs by an outer coat composed of
polyethylene glycol (PEG)-poly-
L-lysine (PLL)-
poly(lactic-co-glycolic acid) (PLGA) NPs. Injection of DNR-Tet-Tf-PEG-PLL-PLGA NPs into nude mice bearing MDR
leukemia cell K562/A02 xenografts was shown to inhibit
tumor growth, and contemporaneous immunohistochemical analysis of
tumor tissue showed the targeted NPs induced apoptosis in
tumor cells. Targeted
tumor cells exhibited a marked increase in Tf receptor expression, with noticeable decreases in
P-glycoprotein, MDR
protein, and nuclear factor κB, as assessed by quantitative real-time polymerase chain reaction and Western blot analysis. Moreover, the concentration of DNR was shown to increase in plasma,
tumor tissue, and major organs. Flow cytometry analysis with a near-infrared fluorescent (NIRF)
dye, NIR797, was used to study the effectiveness of Tf as a targeting group for
leukemia cells, a finding that was supported by NIRF imaging in
tumor-bearing nude mice. In summary, our studies show that DNR-Tet-Tf-PEG-PLL-PLGA NPs provide a specific and effective means to target cytotoxic drugs to MDR
tumor cells.